Deal Round-up 30/10/02

GLSV leads E12m round for Pieris; Optillion takes fundraising to $70m; Opto Speed completes E30m financing round

GLSV leads E12m round for Pieris


German venture capital firm Global Life Science Ventures has led a $12m first round of financing for Pieris Proteolab, a protein engineering company based in Freising, Germany. The financing round included Gilde Investment Management, BayTech Venture Capital, ABN AMRO Capital and BioM Venture Capital.


Pieris Proteolab will use the funding to automate the company’s internal discovery programmes and to advance preclinical studies in oncology, inflammation and cardiovascular disease. The company’s founding investor, Transconnect, has also participated in the round.


Optillion takes fundraising to $70m


A group of venture capital firms comprising Crescendo Ventures, Cisco Systems, ITACT, and Investor Growth Capital have provided $15m in third round financing for Optillion, a Swedish company that develops fibre optic technology. The latest fund takes Optillion’s fundraising over the $70m mark.


The investment will be used to support product development, marketing and sales. As part of the financing round, the company has also announced a series of job cuts as it hopes to adapt to adverse market conditions.


Opto Speed completes E30m financing round


Opto Speed, a developer and manufacturer of optoelectronic modules for the communications, medical and defence markets, has announced that ABN AMRO Capital has joined the E20m second round financing led by The Carlyle Group, bringing the total second round investment in Opto Speed to E30m.


Opto Speed will use the funds to open a US office and increase its sales and marketing activity. In addition, the funds will enable the firm to further research and development of its optical components.